<html>
<head>
<title>Federal Register, Volume 90 Issue 56 (Tuesday, March 25, 2025)</title>
</head>
<body><pre>
[Federal Register Volume 90, Number 56 (Tuesday, March 25, 2025)]
[Notices]
[Page 13610]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2025-04981]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute on Drug Abuse; Notice of Meeting

    Pursuant to section 1009 of the Federal Advisory Committee Act, as 
amended, notice is hereby given of a meeting of the National Advisory 
Council on Drug Abuse.
    The meeting will be held as a virtual meeting and is open to the 
public, as indicated below. Individuals who plan to view the virtual 
meeting and need special assistance such as sign language 
interpretation or other reasonable accommodations to view the meeting, 
should notify Dr. Gillian Acca via email at <a href="mailto:gillian.acca@nih.gov">gillian.acca@nih.gov</a> five 
days in advance of the meeting. The open session will be videocast and 
can be accessed from the NIH Videocasting and Podcasting website 
(<a href="http://videocast.nih.gov/">http://videocast.nih.gov/</a>).
    A portion of the meeting will be closed to the public in accordance 
with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), 
Title 5 U.S.C., as amended. The grant applications and the discussions 
could disclose confidential trade secrets or commercial property such 
as patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Advisory Council on Drug Abuse.
    Date: May 13, 2025.
    Closed: 11:00 a.m. to 12:15 p.m.
    Agenda: To review and evaluate grant applications.
    Open: 1:30 p.m. to 5:00 p.m.
    Agenda: Presentations and other business of the Council.
    Meeting Format: Virtual Meeting.
    Place: National Institutes of Health, National Institute on Drug 
Abuse, 301 North Stonestreet Avenue, Bethesda, MD 20892.
    Contact Person: Susan R.B. Weiss, Ph.D., Director, Division of 
Extramural Research, Office of the Director, National Institute on 
Drug Abuse, NIH, Three White Flint North, RM 09D08, 11601 Landsdown 
Street, Bethesda, MD 20852, 301-443-6480, <a href="mailto:sweiss@nida.nih.gov">sweiss@nida.nih.gov</a>.
    Contact Person: Gillian Acca, Ph.D., Health Scientist 
Administrator, Division of Extramural Research, Office of Extramural 
Policy, National Institute on Drug Abuse, NIH, Three White Flint 
North, RM 09C70, 11601 Landsdown Street, Bethesda, MD 20852, 301-
827-5863, <a href="mailto:gillian.acca@nih.gov">gillian.acca@nih.gov</a>.
    Any interested person may file written comments with the 
committee by forwarding the statement to Dr. Gillian Acca via email 
at <a href="mailto:gillian.acca@nih.gov">gillian.acca@nih.gov</a>. The statement should include the name, 
address, telephone number and when applicable, the business or 
professional affiliation of the interested person.
    Information is also available on the Institute's/Center's home 
page: <a href="http://www.drugabuse.gov/NACDA/NACDAHome.html">www.drugabuse.gov/NACDA/NACDAHome.html</a>, where an agenda and 
any additional information for the meeting will be posted when 
available.

(Catalogue of Federal Domestic Assistance Program Nos. 93.277, Drug 
Abuse Scientist Development Award for Clinicians, Scientist 
Development Awards, and Research Scientist Awards; 93.278, Drug 
Abuse National Research Service Awards for Research Training; 
93.279, Drug Abuse and Addiction Research Programs, National 
Institutes of Health, HHS)

    Dated: March 19, 2025.
David W. Freeman,
Supervisory Program Analyst, Office of Federal Advisory Committee 
Policy.
[FR Doc. 2025-04981 Filed 3-24-25; 8:45 am]
BILLING CODE 4140-01-P


</pre></body>
</html>